Cargando…
Cutaneous lymphocyte antigen expression loss and PD1 positivity in early cutaneous lesions of rapidly progressive mycosis fungoides
KEY CLINICAL MESSAGE: It's important to assess cases both clinically and pathologically for factors potentially predictive of an aggressive clinical course. We concluded that the relative immunosuppressive effects of PD1 may contribute to tumor progression while the lack of staining for cutaneo...
Autores principales: | Ogunrinade, Olakunle, Ahn, Christine S, Gergis, Usama, Yassin, Aminah H, Magro, Cynthia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302628/ https://www.ncbi.nlm.nih.gov/pubmed/25614814 http://dx.doi.org/10.1002/ccr3.103 |
Ejemplares similares
-
Epitheliotropic cutaneous lymphoma (mycosis fungoides) in a dog
por: Bhang, Dong Ha, et al.
Publicado: (2006) -
Secondary Cutaneous Amyloidosis in a Patient with Mycosis Fungoides
por: Nam, Chan Hee, et al.
Publicado: (2017) -
Methotrexate-induced cutaneous ulceration in patients with erythrodermic mycosis fungoides
por: Breneman, Debra L, et al.
Publicado: (2008) -
Psoriasiform mycosis fungoides–cutaneous T-cell lymphoma in an African American
por: Miller, Austinn C., et al.
Publicado: (2023) -
Benefit/risk Ratio of Low-dose Methotrexate in Cutaneous Lesions of Mycosis Fungoides and Sézary Syndrome
por: ALENEZI, Fawaz, et al.
Publicado: (2021)